Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT06487039 · RECRUITING
Trial details
- NCT number
- NCT06487039
- Sponsor
- EyebioKorea, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.